These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 18431350

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N, Brinkmann T, Minami K, Tenderich G, Schulte-Eistrup S, Kleesiek K, Körfer R.
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [Abstract] [Full Text] [Related]

  • 3. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM.
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [Abstract] [Full Text] [Related]

  • 4. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y.
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [Abstract] [Full Text] [Related]

  • 5. Diffusion-weighted magnetic resonance imaging for the detection of ischemic brain lesions in coronary artery bypass graft surgery: relation to extracorporeal circulation and heparinization.
    Mirow N, Zittermann A, Körperich H, Börgermann J, Koertke H, Knobl H, Gieseke J, Ostertun B, Coskun T, Kleesiek K, Burchert W, Gummert JF.
    J Cardiovasc Surg (Torino); 2011 Feb; 52(1):117-26. PubMed ID: 21224820
    [Abstract] [Full Text] [Related]

  • 6. Comparison of polymethoxyethylacrylate-coated circuits with leukocyte filtration and reduced heparinization protocol on heparin-bonded circuits in different risk cohorts.
    Gunaydin S, McCusker K, Vijay V, Isbir S, Sari T, Onur MA, Gurpinar A, Sezgin A, Sargon MF, Tezcaner T, Zorlutuna Y.
    Perfusion; 2006 Nov; 21(6):329-42. PubMed ID: 17312857
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC, Bentley MJ, Gelfand ET, Koshal A, Modry DL, Guenther CR, Etches WS, Stang LJ, Lopushinsky SR.
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V, Kalaycioglu S, Gunaydin S, Imren Y, Gokgoz L, Soncul H, Ersoz A.
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [Abstract] [Full Text] [Related]

  • 11. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
    Suehiro S, Shibata T, Sasaki Y, Hattori K, Kumano H, Hosono M, Kinoshita H.
    Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
    [Abstract] [Full Text] [Related]

  • 12. The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.
    Ranucci M, Cazzaniga A, Soro G, Isgrò G, Frigiola A, Menicanti L.
    J Cardiothorac Vasc Anesth; 2002 Jun; 16(3):316-20. PubMed ID: 12073203
    [Abstract] [Full Text] [Related]

  • 13. Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system.
    Tayama E, Hayashida N, Akasu K, Kosuga T, Fukunaga S, Akashi H, Kawara T, Aoyagi S.
    Artif Organs; 2000 Aug; 24(8):618-23. PubMed ID: 10971248
    [Abstract] [Full Text] [Related]

  • 14. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
    Hayashi Y, Sawa Y, Hirata N, Nishimura M, Ueda H, Naka Y, Yamaguchi T, Ohtake S, Matsuda H.
    J Card Surg; 2002 Aug; 17(6):477-84. PubMed ID: 12643456
    [Abstract] [Full Text] [Related]

  • 15. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E, Am Holen E, Tangen G, Ringdal MA.
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [Abstract] [Full Text] [Related]

  • 16. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M, Hirose Y, Gamo M, Matsuo K.
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [Abstract] [Full Text] [Related]

  • 17. Heparin coating with aprotinin reduces blood activation during coronary artery operations.
    Baufreton C, Jansen PG, Le Besnerais P, te Velthuis H, Thijs CM, Wildevuur CR, Loisance DY.
    Ann Thorac Surg; 1997 Jan; 63(1):50-6. PubMed ID: 8993240
    [Abstract] [Full Text] [Related]

  • 18. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J, Bagge L, Saldeen T, Thelin S.
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [Abstract] [Full Text] [Related]

  • 19. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S, Mccusker K, Vijay V.
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [Abstract] [Full Text] [Related]

  • 20. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
    Aldea GS, Soltow LO, Chandler WL, Triggs CM, Vocelka CR, Crockett GI, Shin YT, Curtis WE, Verrier ED.
    J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.